T-cell prolymphocytic leukemia screening: Difference between revisions
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
==T-cell prolymphocytic leukemia | == Screening== | ||
There is insufficient evidence to recommend routine screening for T-cell prolymphocytic leukemia. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 16:54, 26 March 2019
|
T-cell prolymphocytic leukemia Microchapters |
|
Differentiating T-cell prolymphocytic leukemia historical perspective from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
T-cell prolymphocytic leukemia screening On the Web |
|
American Roentgen Ray Society Images of T-cell prolymphocytic leukemia screening |
|
Risk calculators and risk factors for T-cell prolymphocytic leukemia screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Qurrat-ul-ain Abid, M.D.[2], Maria Fernanda Villarreal, M.D. [3]
|
T-cell prolymphocytic leukemia Microchapters |
|
Differentiating T-cell Prolymphocytic Leukemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
T-cell prolymphocytic leukemia screening On the Web |
|
American Roentgen Ray Society Images of T-cell prolymphocytic leukemia screening |
|
Directions to Hospitals Treating T-cell prolymphocytic leukemia |
|
Risk calculators and risk factors for T-cell prolymphocytic leukemia screening |
Overview
Screening
There is insufficient evidence to recommend routine screening for T-cell prolymphocytic leukemia.